Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA (cytosine-5)-methyltransferase 1 (DNMT1) is a key enzyme responsible for the maintenance of DNA methylation patterns in mammalian cells. It catalyzes the transfer of methyl groups to cytosine residues within CpG dinucleotides, primarily acting on hemimethylated DNA during DNA replication. It plays critical roles in gene silencing, embryonic development, carcinogenesis and regulation of neuron maturation, migration, connectivity, and survival in the adult nervous system. Aberrant activity or mutations are associated with developmental abnormalities and various cancers due to epigenetic dysregulation.
Inhibition of DNA methylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA (cytosine-5)-methyltransferase 1 (DNMT1).